Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 104 for alzheimer's

Edit search filters
  1. Registry for Alzheimer’s Prevention in Wisconsin

    La Crosse, WI

  2. Dominantly Inherited Alzheimer Network (DIAN)

    Jacksonville, FL

  3. Mayo Alzheimer's Disease Research Center

    Jacksonville, FL, Rochester, MN

  4. Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

    Jacksonville, FL, Rochester, MN

  5. A Study to Evaluate Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

    Rochester, MN

  6. Targeting Neuroinflammation as a Contributing Pathology in Alzheimer’s Disease Dementia

    Rochester, MN

  7. A Study to Develop A Family Registry to Collect Alzheimer's Biomarkers

    Jacksonville, FL

  8. Systolic Blood Pressure Intervention Trial: Alzheimer’s, Seniors, and Kidneys

    Jacksonville, FL

  9. Partnership for Early Detection of Alzheimer's Disease Using Advanced MR Technology

    Rochester, MN

  10. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer